Related Experiment Video
Updated: Jun 26, 2026

10:05
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Pharmacological targets revealed by myocardial postconditioning
Dwaine S Burley1, Gary F Baxter
1Welsh School of Pharmacy, Cardiff University, UK.
Current Opinion in Pharmacology
|December 26, 2008
Summary
Postconditioning protects the heart during reperfusion injury by targeting mitochondrial pathways. This intervention may reduce heart attack damage in patients undergoing reperfusion therapy.
Area of Science:
- Cardiology
- Molecular Biology
- Physiology
Background:
- Reperfusion injury poses a significant threat to myocardial tissue during acute myocardial infarction treatment.
- Postconditioning is a protective intervention applied at the onset of reperfusion.
- This strategy has shown promise in limiting infarct size in human clinical studies.
Purpose of the Study:
- To review current research on the molecular mechanisms underlying postconditioning.
- To identify the key signaling pathways involved in myocardial protection during reperfusion.
- To explore the potential for pharmacological induction of postconditioning.
Main Methods:
- Literature review of studies investigating postconditioning.
- Analysis of molecular pathways and cellular events during reperfusion.
- Examination of upstream signaling activated by autacoid factors.
Main Results:
- Postconditioning likely suppresses mitochondrial permeability transition pore opening during early reperfusion.
- This suppression is a critical event in preventing reperfusion-induced cell death.
- Multiple upstream signaling pathways converge on this mitochondrial target.
Conclusions:
- Postconditioning offers a promising therapeutic strategy for limiting myocardial infarct size.
- Understanding the molecular mechanisms is crucial for developing pharmacological interventions.
- Targeting mitochondrial pathways presents realistic opportunities for inducing a protective postconditioned state.
More Related Videos
Related Concept Videos
Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

